CHIBA – Researchers at Chiba University Hospital have developed a new method to detect early signs of cancer through a blood test.
The team, led by Takenori Ochiai, a professor of the second surgical department of the hospital, said it has found that cancer patients often have a certain antibody to the protein p53, which can easily reflect the genetic abnormalities of cancer cells.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see this support page.
We humbly apologize for the inconvenience.
In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.
SUBSCRIBE NOW
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.